Short Interest in PureTech Health plc (OTCMKTS:PTCHF) Expands By 308.3%

PureTech Health plc (OTCMKTS:PTCHFGet Free Report) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 9,800 shares, an increase of 308.3% from the September 30th total of 2,400 shares. Based on an average daily volume of 9,700 shares, the short-interest ratio is currently 1.0 days.

PureTech Health Trading Down 0.1 %

Shares of OTCMKTS PTCHF traded down $0.00 during trading hours on Friday, hitting $1.92. The stock had a trading volume of 1,500 shares, compared to its average volume of 33,606. The firm’s 50-day moving average price is $1.97 and its two-hundred day moving average price is $2.34. PureTech Health has a 52 week low of $1.69 and a 52 week high of $3.00.

About PureTech Health

(Get Free Report)

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.

See Also

Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.